Bought
Maintained
Sold
Other funds holding GSK
Ellevest's GSK Position: Q3 2026 in Review
Ellevest increased its GSK (GSK) stake by 0.38% in Q3 2026, buying an estimated $3.27K and bringing the position to 16,736 shares worth $805K. The position accounts for 0.09% of the portfolio, ranked #157.
Ellevest first reported a position in GSK in Q2 2019 and has held it in 30 quarters since. The position peaked at $961K in Q1 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Ellevest held 16,736 shares of GSK worth $805K as of Q3 2026.
- Ellevest bought 64 GSK shares in Q3 2026, an estimated $3.27K.
- GSK made up 0.09% of Ellevest's portfolio in Q3 2026, its #157 holding.
- Ellevest first reported a position in GSK in Q2 2019 and has held it in 30 quarters since.
- Ellevest's GSK position peaked at $961K in Q1 2026.
- 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.